This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

NGS Sample Preparation Market

NGS Sample Preparation Market

NGS Sample Preparation Market Analysis Report By Product Type (Instruments, Kits, Reagents & Consumables), By Application (Drug & Biomarker Discovery, Diagnostics, Precision Medicines), By End User, By Region - Global Forecast 2022-2032

NGS Sample Preparation Market
FACT5932MR
  • Apr-2022
  • List of Tables : 84
  • List of Figures : 112
  • 170 Pages
  • Healthcare

NGS Sample Preparation Market Outlook (2022-2032)

Sales of NGS sample preparation products were valued at US$ 3.8 Billion in FY 2021, and is likely to exhibit a Y-o-Y increase of 10.5% in 2022, reaching US$ 4.2 Billion.

During the forecast period ranging from 2022 to 2032, market demand is expected to surge at a CAGR of 7.3%, expected to reach US$ 8.5 Billion.

Report Attributes

Details

Anticipated Base Year Value (2021)

US$ 3.8 Billion

Expected Market Value (2022)

US$ 4.2 Billion

Projected Forecast Value (2032)

US$ 8.5 Billion

Global Growth Rate (2022-2032)

7.3% CAGR

Growth Rate of the U.S (2022-2032)

7.1% CAGR

Key Companies

  • QIAGEN
  • Thermo Fisher Scientific Inc.
  • Merck KGaA (Merck Millipore)
  • F. Hoffmann-La Roche Ltd.
  • Agilent Technologies
  • Promega Corporation
  • Illumina Inc.
  • Integrated DNA Technologies Inc. (Danaher Corporation)
  • New England Biolabs
  • Tecan Trading AG

Sequencing-based monitoring is quickly gaining traction as a reliable method of detecting a wide range of bacterial and viral strains, as well as a wide range of unknown diseases. As a result, next-generation sequencing (NGS) is gaining traction as a viable treatment option for a variety of infectious diseases. Furthermore, opportunities are projected to abound throughout chronic illnesses, particularly in cancer and agrigenomics.

Interested to Procure The Data

NGS Sample Preparation Market Revenue Analysis 2015-2021 vs. Future Outlook 2022-2032

Rapid advances in healthcare diagnostics technology have benefited the worldwide market, with governments investing in large clinical and diagnostic laboratories to enable reliable testing for a variety of chronic and infectious diseases. From 2015 to 2021, the industry flourished at a CAGR of 7.5%.

The COVID-19 pandemic boosted growth prospects even more, as healthcare practitioners successfully used enhanced in vitro diagnostic tools and other testing methodologies to determine viral presence among patients. The oncology category appears to have particularly promising future prospects. The market is poised to expand more than 2x during the 2022-2032 forecast period.

NGS sample preparation market forecast by Fact.MR

Prominent NGS Sample Preparation Industry Growth Drivers

Collaborations at the University Level Boosting Prospects for Growth

While NGS is gaining popularity in clinical diagnostics, organizations are encountering challenges with library preparation and other automation tactics. Pipetting workstations have been discovered to promote high throughput processing while limiting flexibility during operations. As a result of this, microfluidic solutions have emerged, which have a lot of promise due to their miniaturization and lower investment costs.

For automation, microfluidic systems are being employed. Microfluidic systems, on the other hand, are very young, with just a few being marketed. As a result, organizations working on NGS sample preparation are collaborating with academic institutions to improve the field of microfluidic systems and pipetting workstations in order to evaluate their use in library preparation processes.

Plant Diseases Can Be Tracked Using NGS Sample Preparation

The use of NGS sample preparation in agriculture is growing, since it aids in the diagnosis of a variety of plant and agricultural diseases. Agricultural genomics, or agrigenomics, is continuing to promote sustainable production, providing solutions to the world's rising food-security issues.

For example, viral genomics is widely used to track the spread of plant-borne viral infections that cause major production and quality losses in a wide range of agricultural crops. Multiple viral detection methods have been developed, and NGS is currently a major focus of this field since it allows for impartial and hypothesis-free examination of plant samples.

Key Challenges Prevalent in the Global NGS Sample Preparation Market

NGS Sample Preparation Market Expansion Impeded by Strict Regulatory Approvals

Because NGS is a precision-based approach to diagnostics, sample preparation products that support it must be in perfect working order. This leads in lower error margins and more precise findings. Regulatory authorities are scrutinizing these items as a result of this.

Because each approval takes a long time owing to the continual need for compliance with multiple rules, product introductions are frequently delayed, restricting appropriate supply in the market. In the coming years, this is likely to be a significant growth stumbling block.

Country-wise Analysis

What is the Growth Outlook for NGS Sample Preparation in the U.S?

Presence of a Strong Healthcare System widening Growth Opportunities

NGS sample preparation adoption prospects in the United States are largely bolstered by the presence of a strong healthcare system. The use of NGS to study illness development and epidemiology by large clinical laboratories is increasing the usage of diverse sample preparation products.

The oncology area is likely to use the majority of NGS sample preparation products, with major firms like Illumina Inc. working nonstop to create NGS-based in vitro diagnostic solutions for cancer. Bio-Rad Laboratories, Agilent Technologies, and Thermo Fisher Scientific are among the other major companies. A CAGR worth 7.1% is projected for the U.S market.

Why are Manufacturers of NGS Sample Preparation Products Looking to India for Future Growth?

Over the years, the Indian Healthcare Industry has grown significantly

The Indian healthcare business has seen substantial growth over the years, with value-based care, smart healthcare, and blockchain technology all making major progress. Furthermore, given the increasing complexity of chronic and infectious illnesses, NGS-based diagnostics has become increasingly important.

NGS screening has been widely used in fields including non-invasive prenatal testing, cancer diagnosis, and bacterial and viral infection diagnosis. Prenatal screening is a promising topic since it can assist conceiving couples in determining the existence of genetic abnormalities in the fetus, such as Down's syndrome. A CAGR of 6.6% is anticipated for the market until 2032.

Country-wise Forecast CAGRs in the NGS Sample Preparation Market

Country wise Analysis

Growth Rate

U.S

7.1%

U.K

7%

China

6.3%

Japan

6.5%

India

6.6%

Category-wise Insights

Why there is such a High Demand for NGS Sample Preparation Kits, Reagents, and Consumables?

Rising Production Volumes by Top Producers throughout the World Widening the Growth

Demand for NGS sample preparation kits, reagents, and consumables is likely to expand in the next years, thanks to rising production volumes by top producers throughout the world. A market share worth 41% is projected for this segment in 2022.

Thermo Fisher Scientific Inc., QIAGEN N.V., and Cytiva Life Sciences are among the leading providers of NGS sample preparation products, with a comprehensive selection of kits, reagents, and consumables.

How is Drug and Biomarker Discovery Expanding the Use Cases for NGS Sample Preparation?

Recent Advances in Drug and Pharmaceutical Ingredient Research are Primarily Driving Uptake

The drug & biomarker discovery domain led the worldwide NGS sample preparation market by application in 2021, and this trend is likely to continue throughout the forecast period. Uptake is mostly being driven by recent advancements in medication and pharmaceutical ingredient research.

NGS has a better sensitivity, allowing entire genome sequences of diseases, even undiscovered species, to be detected. Given the exceptionally high cancer incidence rates, NGS applications for medication and biomarker development in oncology are highly powerful. Over 2/5th of global market revenue is to be contributed by this segment.

An Adaptive Approach to Modern-day Research Needs

Competitive Landscape

Offering new sample items with cutting-edge technology, collaborating with current manufacturers, making acquisitions, and obtaining regulatory clearances are just a few of the important expansion methods used by major industry competitors. The following are some noteworthy developments:

  • QIAGEN N.V. introduced the QIAseq DIRECT SARS-CoV-2 Kit in April 2021, a viral genome enrichment and library preparation solution that would drastically minimize library turnaround times and the usage of plastics in NGS.
  • In addition, Thermo Fisher Scientific approved a formal deal to buy PPD Inc. for US$ 17.4 billion, with the goal of boosting innovation, increasing drug development productivity, and fostering advanced clinical research.
  • Swift Biosciences was bought by Integrated DNA Technologies (IDT) Inc. in May 2021 to expand its NGS library preparation genomics kits for academic, translational, and clinical research. Swift develops and commercializes NGS Library Prep Kits that maximize data output, provide comprehensive coverage, and reduce sequencing costs, while IDT is a leader in developing and production nucleic acid products for academic and commercial research, agriculture, medical diagnostics, pharmaceutical development, and synthetic biology.

Key Segments Covered in the NGS Sample Preparation Industry Report

  • Product Type :

    • NGS Sample Preparation Instruments
    • NGS Sample Preparation Kits, Reagents & Consumables
  • Application :

    • Drug & Biomarker Discovery
    • Diagnostics
    • Precision Medicines
    • Others
      • Agriculture
      • Animal Research
  • End User :

    • Hospitals & Diagnostic Centers
    • Biotechnology & Pharmaceutical Companies
    • Academic & Research Institutes
    • Others
      • CROs
      • CMOs
  • Region :

    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

- FAQs -

As of 2021, Fact.MR estimated the NGS sample preparation market to have reached US$ 3.8 Billion
By 2022, Fact.MR expected demand for NGS sample preparation to reach US$ 4.2 Billion
From 2015-2021, the NGS sample preparation market grew at a 7.3% value CAGR
From 2022-2032, NGS sample preparation demand is likely to surge at a 7.3% CAGR
By 2032, the market for NGS sample preparation is likely to be valued at US$ 8.5 Billion
By 2032, Fact.MR expects the U.S market for NGS Sample Preparation is likely to expand at a 7.1% CAGR
India is expected to register a 6.6% CAGR with regard to the NGS sample preparation industry
Japan is expected to document a CAGR worth 6.5% in the NGS sample preparation market
Demand for NGS sample preparation kits, reagents, and consumables is likely to expand in the next years, thanks to rising production volumes by top producers throughout the world.

Need an Exclusive Report for your Unique Requirement?

- Our Clients -

Report Client